Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation
复制标题
DOI:
10.1038/s41375-019-0654-y
复制
发表时间:
2020-05-01
期刊:
影响因子:
11.4
通讯作者:
Villard, Jean
中科院分区:
文献类型:
--
作者:
Buhler, Stephane;Bettens, Florence;Villard, Jean
After allogeneic hematopoietic stem cell transplantation (HSCT), immune reconstitution leads to the development of a new T-cell repertoire. Immune reconstitution could be influenced by events such as conditioning, infections, and graft versus host disease (GVHD). Factors influencing the TCR diversity are of great interest to fine-tune the strategy for donor selection and to optimize standard of care. In this work, immunosequencing of the TCR CDR3 beta region was carried out in a large cohort of 116 full chimeric recipients at 1 year post-HSCT and their respective donors prior to transplantation. The repertoire overlap before and after HSCT was minimal, supporting de novo reconstitution as a primary pathway at any age. Among the parameters investigated, increased patient and/or donor age as well as positive CMV serologic status reinforced by CMV infection/reactivation were the ones significantly associated with a reduced diversity at 1 year post-HSCT. CMV-specific T-cell clones were shown to influence the clonality of the repertoire alongside the expansion of limited numbers of non-CMV T-cell populations. Interestingly, at the exception of CMV infection/reactivation, TCR diversity was not predictive of GVHD, relapse, death, or infections post-HSCT.